NYSE American - Delayed Quote USD
Perspective Therapeutics, Inc. (CATX)
3.3200
+0.2000
+(6.41%)
At close: June 6 at 4:00:00 PM EDT
3.3400
+0.02
+(0.60%)
After hours: June 6 at 7:50:44 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 13.98M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
WOODS LORI A. Director | Purchase at price 2.13 per share. | Indirect | 49,999 | Mar 31, 2025 |
WILLIAMSON ROBERT F III Director | Purchase at price 2.14 - 2.27 per share. | Direct | 132,151 | Mar 31, 2025 |
SPOOR JOHAN M Chief Executive Officer | Purchase at price 2.21 - 2.24 per share. | Indirect | 59,673 | Mar 28, 2025 |
GRAHAM JUAN Chief Financial Officer | Purchase at price 2.25 per share. | Direct | 74,946 | Mar 28, 2025 |
HENSON HEIDI Director | Purchase at price 3.85 per share. | Indirect | 100,004 | Dec 4, 2024 |
SPOOR JOHAN M Chief Executive Officer | Purchase at price 3.77 per share. | Direct | 30,132 | Dec 4, 2024 |
HUNT JONATHAN ROBERT Chief Financial Officer | Purchase at price 3.55 - 3.94 per share. | Direct | 48,974 | Nov 25, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 3.62 - 3.67 per share. | Direct | 22,814 | Nov 25, 2024 |
SPOOR JOHAN M Chief Executive Officer | Purchase at price 3.78 - 3.80 per share. | Indirect | 100,468 | Nov 25, 2024 |
HUNT JONATHAN ROBERT Chief Financial Officer | Purchase at price 1.03 per share. | Direct | 1,861 | Jun 17, 2024 |
WOODS LORI A. Director | Purchase at price 1.07 per share. | Indirect | 4,908 | Jun 14, 2024 |
SPOOR JOHAN M Chief Executive Officer | Purchase at price 1.17 per share. | Direct | 117,430 | Jun 13, 2024 |
WOODS LORI A. Director | Purchase at price 1.46 per share. | Indirect | 49,992 | Jun 3, 2024 |
HUNT JONATHAN ROBERT Chief Financial Officer | Purchase at price 1.40 per share. | Direct | 35,007 | May 31, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 1.38 per share. | Direct | 75,900 | May 31, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 1.32 - 1.34 per share. | Direct | 40,014 | May 29, 2024 |
AUSTIN MARK JOHN Chief Financial Officer | Conversion of Exercise of derivative security at price 0.36 per share. | Direct | 10,800 | Apr 23, 2024 |
LANTHEUS ALPHA THERAPY, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.95 per share. | Indirect | 57,409,487 | Mar 6, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 0.70 - 0.72 per share. | Direct | 90,710 | Jan 30, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 0.54 - 0.64 per share. | Direct | 78,474 | Jan 29, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 0.49 per share. | Direct | 25,478 | Jan 25, 2024 |
PUHLMANN MARKUS Officer | Purchase at price 0.50 per share. | Direct | 139,888 | Jan 24, 2024 |
WILLIAMSON ROBERT F III Director | Purchase at price 0.33 per share. | Indirect | 1,203 | Dec 21, 2023 |
WILLIAMSON ROBERT F III Director | Purchase at price 0.26 - 0.32 per share. | Direct | 6,978 | Dec 19, 2023 |
PUHLMANN MARKUS Officer | Purchase at price 0.26 - 0.34 per share. | Direct | 188,737 | Dec 19, 2023 |
HUNT JONATHAN ROBERT Chief Financial Officer | Purchase at price 0.26 per share. | Direct | 32,338 | Dec 18, 2023 |
WOODS LORI A. Director | Purchase at price 0.27 per share. | Indirect | 49,989 | Dec 15, 2023 |
Related Tickers
CERS Cerus Corporation
1.5100
+9.42%
RSLS ReShape Lifesciences Inc.
4.1800
-1.65%
HYPR Hyperfine, Inc.
0.7962
-7.61%
BJDX Bluejay Diagnostics, Inc.
2.2500
+48.03%
HSDT Helius Medical Technologies, Inc.
1.0900
-4.39%
VERO Venus Concept Inc.
3.1800
+33.05%
PTHL Pheton Holdings Ltd
13.50
+51.69%
BSGM BioSig Technologies, Inc.
7.33
+27.70%
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.7260
-3.20%
CTKB Cytek Biosciences, Inc.
3.4400
+2.99%